Science with a
Patient Focus
Pillar Biosciences was founded by a vision to revolutionize next-generation sequencing (NGS) in the clinical setting, particularly for cancer diagnostics. Recognizing several challenges with existing NGS technologies that hindered widespread adoption in clinical environments, we set out to make NGS simpler, faster, more accurate and accessible for patients and healthcare providers. The result is an NGS technology that is simple, streamlined practical for everyday laboratory use.
Simplifying NGS
Pillar Biosciences’ mission is to make NGS more actionable and accessible for laboratories across the globe. By addressing key challenges in sample processing, data analysis, and overall workflow efficiency, we aim to accelerate the adoption of precision medicine. Our mission was shaped by several key objectives:
Simplifying NGS for routine laboratory use
Our proprietary SLIMamp® library preparation technology allows for overlapping multiplex PCR in a single tube, streamlining a laboratory’s NGS workflow and enabling efficient, automatable, platform-agnostic sequencing.
Accelerating NGS turnaround time
Faster genomic results are key helping inform patient care. By optimizing and rationalizing laboratory and bionformatic processes and platforms, we help laboratory leaders and treating clinicians make more timely, efficient and cost-effective patient care decisions.
Delivering results when others can’t
We design optimized RUO and IVD targeted NGS panels that work reliably with limited or degraded DNA, reducing assay failures and ensuring more patients benefit from precision medicine.
Enabling Affordable NGS Testing
Laboratory economics are critical to making genomic testing more cost-effective and available at a global scale. By simplifying NGS, laboratories can perform high-quality, in-house genomic testing in days, not weeks, significantly reducing turnaround time and operational costs while improving quality of patient care.Our Impact
Today, Pillar Biosciences is a leading provider of kitted next-generation sequencing (NGS) panels. Our products are focused on delivering rapid, sensitive and cost-effective genomic results, improving cancer diagnostics and time to treatment selection. Laboratories around the world utilize our proprietary SLIMamp® technology to enable simple, single-tube NGS library prep, reducing complexity and hands-on time while supporting automation and high-throughput genomic testing.
Our oncoReveal® portfolio of NGS kitted panels offers a broad range of 20+ oncology-focused products covering solid tumors, hematologic cancers, and liquid biopsy, ensuring reliable results even from challenging or low-quality samples. Validated by leading academic institutions and national laboratories, Pillar’s simple and robust panels empower front-line NGS testing, helping clinicians make timely, informed decisions.
Pillar Biosciences in the News
Stay up to date with the latest news from Pillar Biosciences. Here, you’ll find timely updates on our scientific advancements, strategic partnerships, product launches, and company growth. Explore our press releases to see how Pillar Biosciences is shaping the future of precision diagnostics and enabling Decision MedicineTM.Want to be the first to know about new
and exciting news at Pillar Biosciences?
Sign up for our mailing list here.